Anavex Life Sciences Corp (AVXL)

[georgejjl]

AVXL should be worth at least $30 per share before the end of 2015

Aricept had peak sales of $3.5 BILLION PER YEAR.

Anavex 2-73 appears to be much more effective at treating Alzheimer's disease that Aricept (donepezil)

Pharmaceutical companies have an average P/E Ratio (Price to Earnings Ratio) of about 20.

AVXL should be worth at least $150 per share by late July 2016 and $350 per share by late July 2017.

Of course AVXL will be most probably bought out by one of the large pharmaceutical companies before July 2017 and possibly before July 2016.

Good luck and GOD bless,

George